Kneat.com Inc (KSI.V)

(A Top Pick Aug 22/22, Down 17%)

Software company that is based in Ireland. 
Offers compliance and validation software in life sciences business.
Currently has 8/10 of top pharma & 18/20 top bio-pharma companies as customers. 
Growing customer base at a rapid rate.
Very positive on outlook of business.
Will continue to own shares.

Has developed propriety software product to aid with compliance in the life science industry. Business has very high barriers to entry. Customer list includes 8 of the top 10 pharma companies. 60 contracted customers going forward.

A company that has a software to bring efficiency to the pharmaceutical industry. It helps with work flows. Their strategy is land and expand. Results were better than expected. The sales cycle is long. There is significant upside as they convert to sales and visible recurring revenue. Higher profitability is on the horizon.